Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Lifeway Foods director Smolyansky sells $679,200 in shares

Lifeway Foods director Smolyansky sells $679,200 in shares

Edward Smolyansky, a top executive at Lifeway Foods, recently divested himself of a substantial portion of his stake in the company. On October 13, 2026, he disposed of 30,000 shares of Lifeway Foods common stock, generating a total of $679,200. The shares were sold at prices ranging from $22.50 to $23.49, while the stock is currently trading at $22.21, marking a significant decline of approximately 32% from its 52-week peak of $32.71.

LWAY's market capitalization stands at $335 million, and the company's price-to-earnings ratio is calculated at 32.12. Analysis from InvestingPro indicates that the stock is trading close to its fair value, with the business demonstrating profitability and robust financial performance over the past five years.

Following the completion of these share sales, Mr. Smolyansky's direct ownership of Lifeway Foods common stock is reduced to 902,642 shares. He also holds an indirect interest of 864,793 shares through the Edward Smolyansky Trust 2/2/16, where he serves as trustee. Additionally, his 902,642 shares and his son's 100,000 shares are both disclaimed in terms of beneficial ownership, except for any pecuniary interest.

Smolyansky Holding LLC maintains a 500,000 share position, with similar disclaimers applied. Despite the significant sale, Lifeway Foods reported strong financial results in its second quarter of 2026, with sales soaring to $66.9 million, a 24.1% increase compared to the previous year, exceeding market expectations. However, the company's net income was modest at $0.1 million, or $0.01 per share, attributed to rising costs in milk, resin, and transportation.

The stock received favorable attention from analysts, with Freedom Broker upgrading Lifeway Foods to a Buy rating and increasing its price target to $32, while StoneX maintained a Buy rating with a higher price target of $35. BTIG also initiated coverage with a Buy rating and a price target of $32, emphasizing the company's growth prospects in the probiotic kefir market.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at investing.com →

More in Finance & Markets

Baltic Dry Index Extends Slide

The Baltic Exchange’s dry bulk freight index, which tracks rates for ships carrying dry bulk commodities, slumped about 4.6% to its lowest since june 30 at 2,545 points on Thursday, marking the ninth…

More from Thursday 15 October →